Status:
COMPLETED
CAP Pilot Study for Obstructive Sleep Apnea (OSA)
Lead Sponsor:
Fisher and Paykel Healthcare
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
21-75 years
Brief Summary
This is a pilot to review the feasibility of a program that assists patients towards therapy compliance by scheduled intervention through the first month of therapy. The hypothesis of this study is th...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- 21 to 75 years of age
- Diagnosed with OSA (AHI \>5 events/hour) and eligible for Continuous Positive Airway Pressure (CPAP) treatment under local requirements
- Must be initiated on program (i.e. received their device) within 12 weeks of CPAP titration study
- Naïve to CPAP therapy, i.e have not been prescribed CPAP in the past
- Access to a cellphone
- Exclusion Criteria:
- Contraindicated for CPAP therapy
- Medically unstable condition/diagnosis that is not yet under control
- Co-existing sleep disorder (however clinically diagnosed insomnia can be included in the study)
- Periodic Leg MOvement Arousal Index greater than 15/hr
- Home titration of longer than 5 days
Exclusion
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02309749
Start Date
April 1 2013
End Date
December 1 2014
Last Update
December 8 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Clayton Sleep Institute
St Louis, Missouri, United States
2
Sleep Therapy Research Center
San Antonio, Texas, United States